|
|
Volumn 4, Issue 2, 2002, Pages 131-141
|
|
Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: Children's Cancer Group trials.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
CENTRAL NERVOUS SYSTEM TUMOR;
CHILD;
CHILD BEHAVIOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
HUMAN;
INFANT;
NEWBORN;
PRESCHOOL CHILD;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
CHILD;
CHILD BEHAVIOR;
CHILD, PRESCHOOL;
DISEASE-FREE SURVIVAL;
HUMANS;
INFANT;
INFANT, NEWBORN;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
|
EID: 0036514602
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-002-0074-3 Document Type: Review |
|
Times cited : (7)
|
|
References (50)
|
